Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker

(2013) Masahiro Hirakawa et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A reliable risk score for stage IV esophagogastric cancer

(2013) S. Blank et al.   EJSO

Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery

(2012) Karen Becker et al.   ANNALS OF SURGERY

Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients

(2012) Sylvie Lorenzen et al.   ANNALS OF SURGICAL ONCOLOGY

Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor

(2012) Katja Ott et al.   LANGENBECKS ARCHIVES OF SURGERY

Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer

(2011) Katja Ott et al.   ANNALS OF SURGICAL ONCOLOGY

Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer

(2011) M. van Heijl et al.   EJSO

Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel

(2011) Nils Homann et al.   INTERNATIONAL JOURNAL OF CANCER

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial

(2011) C. Meyer zum Buschenfelde et al.   JOURNAL OF NUCLEAR MEDICINE

Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients

(2011) Susanne Blank et al.   LANGENBECKS ARCHIVES OF SURGERY

Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)

(2010) Christian Jost et al.   GASTROINTESTINAL ENDOSCOPY

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

(2010) Christoph Schuhmacher et al.   JOURNAL OF CLINICAL ONCOLOGY

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma

(2009) Gertraud Stocker et al.   EUROPEAN JOURNAL OF CANCER

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis

(2008) E. Bollschweiler et al.   ANNALS OF ONCOLOGY

Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

(2008) Paul M. Schneider et al.   ANNALS OF SURGERY

Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study

(2008) K. Ott et al.   CLINICAL CANCER RESEARCH

Paclitaxel in the Neoadjuvant Treatment for Adeno carcinoma of the Distal Esophagus (AEG I). A Comparison of Two Phase II Trials with Long-Term Follow-Up

(2008) Franz G. Bader et al.   ONKOLOGIE